With biotech investing, you have to get used to that.
Waiting is business as usual at DVAX.
The biggest thing which happens here is.............nothing.
Nothing occurs most of the time. (I'm pretty sure that I wrote that a couple of times here)
If DVAX had a product or a reputation as a winner, it might move up based on sales, earnings, etc or the reasonable expectation that they will inevitably pull something good out of the hat in the not so distant future.
DVAX has none of that and a reputation as a "challenged" company.
Therefore, you had $2 in January, $1.60 in April, $1.30 in July and now $1.50 on some slight recovery.
See any trend there?
Like I wrote, one item of bad luck now in this period and it could be some VERY tough sledding for this sad little puppy.........